SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.

Contains fulltext : 53236.pdf (Publisher’s version ) (Closed access) One pedigree with four patients has been recently described with mitochondrial DNA depletion and mutation in SUCLA2 gene leading to succinyl-CoA synthase deficiency. Patients had a Leigh-like encephalomyopathy and deafness but besi...

Full description

Bibliographic Details
Published in:Brain
Main Authors: Carrozzo, R., Dionisi-Vici, C., Steuerwald, U., Lucioli, S., Deodato, F., Giandomenico, S. Di, Bertini, E., Franke, B., Kluijtmans, L.A.J., Meschini, M.C., Rizzo, C., Piemonte, F., Rodenburg, R.J.T., Santer, R., Santorelli, F.M., Rooij, A. van, Vermunt-de Koning, D.G.M., Morava, E., Wevers, R.A.
Format: Article in Journal/Newspaper
Language:unknown
Published: 2007
Subjects:
Online Access:http://hdl.handle.net/2066/53236
https://doi.org/10.1093/brain/awl389
id ftunivnijmegen:oai:repository.ubn.ru.nl:2066/53236
record_format openpolar
spelling ftunivnijmegen:oai:repository.ubn.ru.nl:2066/53236 2023-11-12T04:16:58+01:00 SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Carrozzo, R. Dionisi-Vici, C. Steuerwald, U. Lucioli, S. Deodato, F. Giandomenico, S. Di Bertini, E. Franke, B. Kluijtmans, L.A.J. Meschini, M.C. Rizzo, C. Piemonte, F. Rodenburg, R.J.T. Santer, R. Santorelli, F.M. Rooij, A. van Vermunt-de Koning, D.G.M. Morava, E. Wevers, R.A. 2007 http://hdl.handle.net/2066/53236 https://doi.org/10.1093/brain/awl389 unknown http://hdl.handle.net/2066/53236 doi:10.1093/brain/awl389 Brain, 130, Pt 3, pp. 862-74 DCN 1: Perception and Action DCN 2: Functional Neurogenomics DCN 3: Neuroinformatics EBP 1: Determinants in Health and Disease IGMD 3: Genomic disorders and inherited multi-system disorders IGMD 4: Glycostation disorders IGMD 8: Mitochondrial medicine NCMLS 4: Energy and redox metabolism NCMLS 6: Genetics and epigenetic pathways of disease UMCN 3.1: Neuromuscular development and genetic disorders UMCN 3.2: Cognitive neurosciences UMCN 5.1: Genetic defects of metabolism Article / Letter to editor 2007 ftunivnijmegen https://doi.org/10.1093/brain/awl389 2023-10-25T22:09:44Z Contains fulltext : 53236.pdf (Publisher’s version ) (Closed access) One pedigree with four patients has been recently described with mitochondrial DNA depletion and mutation in SUCLA2 gene leading to succinyl-CoA synthase deficiency. Patients had a Leigh-like encephalomyopathy and deafness but besides the presence of lactic acidosis, the profile of urine organic acid was not reported. We have studied 14 patients with mild 'unlabelled' methylmalonic aciduria (MMA) from 11 families. Eight of the families are from the Faroe Islands, having a common ancestor, and three are from southern Italy. Since the reaction catalysed by succinyl-CoA synthase in the tricarboxylic acid (TCA) cycle represents a distal step of the methylmalonic acid pathway, we investigated the SUCLA2 gene as a candidate gene in our patients. Genetic analysis of the gene in the 14 patients confirmed the defect in all patients and led to the identification of three novel mutations (p.Gly118Arg; p.Arg284Cys; c.534 + 1G --> A). The defect could be convincingly shown at the protein level and our data also confirm the previously described mitochondrial DNA depletion. Defects in SUCLA2 can be found at the metabolite level and are defined by mildly elevated methylmalonic acid and C4-dicarboxylic carnitine concentrations in body fluids in association with variable lactic acidosis. Clinically the diagnosis should be considered in patients with early/neonatal onset encephalomyopathy, dystonia, deafness and Leigh-like MRI abnormalities mainly affecting the putamen and the caudate nuclei. The frequency of the mutated allele in the Faroese population amounted to 2%, corresponding with an estimated homozygote frequency of 1 : 2500. Our data extend knowledge on the genetic defects causing MMA. Our patients present with an early infantile Leigh-like encephalomyopathy with deafness, and later on a progressive dystonia. Mild MMA, lactic acidosis and specific abnormalities in the carnitine ester profile are the biochemical hallmarks of the disease. In view of ... Article in Journal/Newspaper Faroe Islands Radboud University: DSpace Faroe Islands Brain 130 3 862 874
institution Open Polar
collection Radboud University: DSpace
op_collection_id ftunivnijmegen
language unknown
topic DCN 1: Perception and Action
DCN 2: Functional Neurogenomics
DCN 3: Neuroinformatics
EBP 1: Determinants in Health and Disease
IGMD 3: Genomic disorders and inherited multi-system disorders
IGMD 4: Glycostation disorders
IGMD 8: Mitochondrial medicine
NCMLS 4: Energy and redox metabolism
NCMLS 6: Genetics and epigenetic pathways of disease
UMCN 3.1: Neuromuscular development and genetic disorders
UMCN 3.2: Cognitive neurosciences
UMCN 5.1: Genetic defects of metabolism
spellingShingle DCN 1: Perception and Action
DCN 2: Functional Neurogenomics
DCN 3: Neuroinformatics
EBP 1: Determinants in Health and Disease
IGMD 3: Genomic disorders and inherited multi-system disorders
IGMD 4: Glycostation disorders
IGMD 8: Mitochondrial medicine
NCMLS 4: Energy and redox metabolism
NCMLS 6: Genetics and epigenetic pathways of disease
UMCN 3.1: Neuromuscular development and genetic disorders
UMCN 3.2: Cognitive neurosciences
UMCN 5.1: Genetic defects of metabolism
Carrozzo, R.
Dionisi-Vici, C.
Steuerwald, U.
Lucioli, S.
Deodato, F.
Giandomenico, S. Di
Bertini, E.
Franke, B.
Kluijtmans, L.A.J.
Meschini, M.C.
Rizzo, C.
Piemonte, F.
Rodenburg, R.J.T.
Santer, R.
Santorelli, F.M.
Rooij, A. van
Vermunt-de Koning, D.G.M.
Morava, E.
Wevers, R.A.
SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.
topic_facet DCN 1: Perception and Action
DCN 2: Functional Neurogenomics
DCN 3: Neuroinformatics
EBP 1: Determinants in Health and Disease
IGMD 3: Genomic disorders and inherited multi-system disorders
IGMD 4: Glycostation disorders
IGMD 8: Mitochondrial medicine
NCMLS 4: Energy and redox metabolism
NCMLS 6: Genetics and epigenetic pathways of disease
UMCN 3.1: Neuromuscular development and genetic disorders
UMCN 3.2: Cognitive neurosciences
UMCN 5.1: Genetic defects of metabolism
description Contains fulltext : 53236.pdf (Publisher’s version ) (Closed access) One pedigree with four patients has been recently described with mitochondrial DNA depletion and mutation in SUCLA2 gene leading to succinyl-CoA synthase deficiency. Patients had a Leigh-like encephalomyopathy and deafness but besides the presence of lactic acidosis, the profile of urine organic acid was not reported. We have studied 14 patients with mild 'unlabelled' methylmalonic aciduria (MMA) from 11 families. Eight of the families are from the Faroe Islands, having a common ancestor, and three are from southern Italy. Since the reaction catalysed by succinyl-CoA synthase in the tricarboxylic acid (TCA) cycle represents a distal step of the methylmalonic acid pathway, we investigated the SUCLA2 gene as a candidate gene in our patients. Genetic analysis of the gene in the 14 patients confirmed the defect in all patients and led to the identification of three novel mutations (p.Gly118Arg; p.Arg284Cys; c.534 + 1G --> A). The defect could be convincingly shown at the protein level and our data also confirm the previously described mitochondrial DNA depletion. Defects in SUCLA2 can be found at the metabolite level and are defined by mildly elevated methylmalonic acid and C4-dicarboxylic carnitine concentrations in body fluids in association with variable lactic acidosis. Clinically the diagnosis should be considered in patients with early/neonatal onset encephalomyopathy, dystonia, deafness and Leigh-like MRI abnormalities mainly affecting the putamen and the caudate nuclei. The frequency of the mutated allele in the Faroese population amounted to 2%, corresponding with an estimated homozygote frequency of 1 : 2500. Our data extend knowledge on the genetic defects causing MMA. Our patients present with an early infantile Leigh-like encephalomyopathy with deafness, and later on a progressive dystonia. Mild MMA, lactic acidosis and specific abnormalities in the carnitine ester profile are the biochemical hallmarks of the disease. In view of ...
format Article in Journal/Newspaper
author Carrozzo, R.
Dionisi-Vici, C.
Steuerwald, U.
Lucioli, S.
Deodato, F.
Giandomenico, S. Di
Bertini, E.
Franke, B.
Kluijtmans, L.A.J.
Meschini, M.C.
Rizzo, C.
Piemonte, F.
Rodenburg, R.J.T.
Santer, R.
Santorelli, F.M.
Rooij, A. van
Vermunt-de Koning, D.G.M.
Morava, E.
Wevers, R.A.
author_facet Carrozzo, R.
Dionisi-Vici, C.
Steuerwald, U.
Lucioli, S.
Deodato, F.
Giandomenico, S. Di
Bertini, E.
Franke, B.
Kluijtmans, L.A.J.
Meschini, M.C.
Rizzo, C.
Piemonte, F.
Rodenburg, R.J.T.
Santer, R.
Santorelli, F.M.
Rooij, A. van
Vermunt-de Koning, D.G.M.
Morava, E.
Wevers, R.A.
author_sort Carrozzo, R.
title SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.
title_short SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.
title_full SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.
title_fullStr SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.
title_full_unstemmed SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.
title_sort sucla2 mutations are associated with mild methylmalonic aciduria, leigh-like encephalomyopathy, dystonia and deafness.
publishDate 2007
url http://hdl.handle.net/2066/53236
https://doi.org/10.1093/brain/awl389
geographic Faroe Islands
geographic_facet Faroe Islands
genre Faroe Islands
genre_facet Faroe Islands
op_source Brain, 130, Pt 3, pp. 862-74
op_relation http://hdl.handle.net/2066/53236
doi:10.1093/brain/awl389
op_doi https://doi.org/10.1093/brain/awl389
container_title Brain
container_volume 130
container_issue 3
container_start_page 862
op_container_end_page 874
_version_ 1782333982212358144